Insights On Partnering
-
An Introduction To One Home for Sites™
4/18/2024
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
-
Stipends Create More Tax Burden — Here's A Better Option
7/22/2025
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
-
Maximize Your DHT Investment With ActiGraph Scientific Services
2/16/2024
Discover how the ActiGraph Science Team collaborates closely with study teams to capture meaningful clinical outcomes remotely and continuously using sensor-based Digital Health Technologies.
-
Are You Paying Participants Enough? Your Top Questions Answered
6/24/2025
Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.
-
The Asia Advantage: Why US Biotechs Should Look East For Clinical Trials
8/7/2024
Explore the compelling reasons behind the Asia Advantage and highlights how Avance Clinical's strategic expansion into the region supports biotechs in maximizing these benefits.
-
Clinical Leader Smart Sourcing Solutions Expo: Retention By Design
9/9/2025
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
Dispelling Common Clinical Trial Oversight Myths
6/17/2025
Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.
-
Breaking Through Barriers With Integrated Trial Optimization
5/9/2025
In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.
-
PV Solutions Optimizing End-To-End Safety In Clinical Development
3/6/2024
Explore what the future of PV services and technology in the life sciences industry could look like if innovation, regulatory vigilance, and collaboration with regulatory bodies were prioritized.
-
Highlights From The 2025 International Hepatitis B Meeting
11/7/2025
For biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.